Big drug makers have been reporting revenue shortfalls due to currency issues, price cuts in Europe and a sharper-than-expected impact on big drug sales from patent expirations. Today, Pfizer (PFE) joined the club. The nation’s largest pharmaceutical company announced third-quarter profit fell 14% on declining sales of its cholesterol drug, Lipitor, which lost U.S. market [...]